Copyright
©The Author(s) 2024.
World J Clin Oncol. Jan 24, 2024; 15(1): 45-61
Published online Jan 24, 2024. doi: 10.5306/wjco.v15.i1.45
Published online Jan 24, 2024. doi: 10.5306/wjco.v15.i1.45
Table 1 Demographic and clinicopathological parameters of high and low HSPA4 expression group patients in The Cancer Genome Atlas - lung adenocarcinoma, n (%)
| Characteristics | Low expression of HSPA4 | High expression of HSPA4 | P value |
| n | 269 | 270 | |
| Pathologic T stage | 0.141 | ||
| T1 | 99 (18.5) | 77 (14.4) | |
| T2 | 137 (25.6) | 155 (28.9) | |
| T3 & T4 | 33 (6.2) | 35 (6.5) | |
| Pathologic N stage | 0.028 | ||
| N0 | 189 (36.1) | 161 (30.8) | |
| N1 | 41 (7.8) | 56 (10.7) | |
| N2 & N3 | 31 (5.9) | 45 (8.6) | |
| Pathologic stage | 0.012 | ||
| Stage I | 163 (30.7) | 133 (25) | |
| Stage II | 58 (10.9) | 67 (12.6) | |
| Stage III & Stage IV | 43 (8.1) | 67 (12.6) | |
| Gender | 0.410 | ||
| Female | 149 (27.6) | 140 (26) | |
| Male | 120 (22.3) | 130 (24.1) | |
| Primary therapy outcome | < 0.001 | ||
| PD | 22 (4.9) | 49 (10.9) | |
| SD & PR | 22 (4.9) | 22 (4.9) | |
| CR | 186 (41.4) | 148 (33) | |
| OS event | 0.002 | ||
| Alive | 190 (35.3) | 157 (29.1) | |
| Dead | 79 (14.7) | 113 (21) |
- Citation: Wu X, Yang SY, Zhang YH, Fang JZ, Wang S, Xu ZW, Zhang XJ. Prognostic and immunological roles of heat shock protein A4 in lung adenocarcinoma. World J Clin Oncol 2024; 15(1): 45-61
- URL: https://www.wjgnet.com/2218-4333/full/v15/i1/45.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i1.45